- Home
- KRKR vs TOVX Comparison
KRKR vs TOVX Comparison
Compare KRKR & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRKR | TOVX |
|---|---|---|
| Founded | 2010 | 2001 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8M | 7.2M |
| IPO Year | 2019 | 2006 |
Fundamental Metrics
Financial Performance| Metric | KRKR | TOVX |
|---|---|---|
| Price | $4.88 | $0.19 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 6.3K | ★ 10.6M |
| Earning Date | 09-26-2025 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $30,966,526.00 | N/A |
| Revenue This Year | $182.55 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.30 | $0.17 |
| 52 Week High | $21.36 | $1.75 |
Technical Indicators
Market Signals| Indicator | KRKR | TOVX |
|---|---|---|
| Relative Strength Index (RSI) | 55.97 | 43.94 |
| Support Level | $4.32 | $0.18 |
| Resistance Level | $5.77 | $0.21 |
| Average True Range (ATR) | 0.47 | 0.01 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 56.50 | 25.10 |
Price Performance
Historical ComparisonAbout KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.